Skip to main content

Table 3 Participating medical centres and the inclusion estimations. The participating centres of the DOLPHIN trial, the date of the start of the study and the estimated inclusions in study sites

From: The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial

Study sites Start date Expected enrollment
Erasmus Medical Center (Rotterdam) 01–11–2018 100
Haaglanden Medical Center (The Hague) 01-07-2019 50
Haga Hospital (The Hague) 01-07-2019 50
Franciscus Gasthuis en Vlietland (Rotterdam) 01-07-2019 50
Amphia Hospital (Breda) 01-10-2019 50
Groene Hart Hospital (Gouda) 01-12-2019 50
Isala Hospital (Zwolle) 01-12-2019 50
Diakonessenhuis (Utrecht) 01–01–2020 50